文献速递关节外科创伤骨科

金黄色葡萄球菌在两步法翻修关节置换术两阶段间的抗生素敏感性变化

Changes in Antibiotic Susceptibility of Staphylococcus aureus Between the Stages of 2-Stage Revision Arthroplasty.
PubMed 文献 · J Arthroplasty · 2018-03-02

基于2000至2015年两家学术机构1614例因假体周围感染行两步法翻修髋/膝关节置换术的病例,其中第一阶段培养出金黄色葡萄球菌402例(24.9%),第二阶段持续培养阳性30例(膝18例、髋12例)。比较两阶段最小抑菌浓度发现,9例(30%)万古霉素MIC升高,且这9例均在间隔物中使用了万古霉素。

要点

  • 1614例两步法翻修中第一阶段金黄色葡萄球菌检出402例(24.9%),第二阶段持续阳性30例。
  • 30例持续阳性中9例(30%)万古霉素MIC升高,其中6例由≤0.5升至1 μg/mL。
  • 9例万古霉素MIC升高的翻修均在骨水泥间隔物中使用了万古霉素。

核心结论

  • 在约三分之一的翻修中观察到万古霉素MIC升高,万古霉素是骨水泥间隔物中广泛使用的抗生素。
  • 尽管样本量小,这项初步研究的数据引起对两步法翻修两阶段间可能出现耐药微生物的担忧。

研究设计与样本

  • 回顾性识别2000至2015年两家学术机构因假体周围感染行两步法翻修髋/膝关节置换术共1614例。
  • 第一阶段(切除关节成形术)培养出金黄色葡萄球菌(甲氧西林敏感和/或耐药)402例(24.9%)。
  • 第二阶段持续培养出金黄色葡萄球菌30例(膝18例、髋12例),收集MIC、人口学、抗生素治疗及手术史,比较两阶段MIC。

主要发现

  • 9例(30%)翻修万古霉素MIC升高:6例由≤0.5升至1 μg/mL,2例由≤0.5升至2 μg/mL,1例由1升至2 μg/mL。
  • 9例万古霉素MIC升高的翻修均在间隔物中使用了万古霉素。

局限性

  • 原文述样本量小。
  • 原文称该数据来自初步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staphylococcus aureus is the predominant cause of periprosthetic joint infection (PJI) and can persist at the time of planned second stage of 2-stage revision arthroplasty, despite antibiotic cement spacer insertion and parenteral antibiotic therapy. Given the rapid emergence of antibiotic resistance, it is important to determine whether the antibiotic susceptibility of microorganisms changes between the stages of a 2-stage revision. METHODS: A total of 1614 2-stage revision hip/knee arthroplasties performed for PJI at 2 academic institutions from 2000 to 2015 were identified. S aureus (methicillin susceptible and/or resistant) was isolated by culture in 402 (24.9%) cases during the first stage (resection arthroplasty). S aureus persisted and was cultured in 30 cases (knees = 18, hips = 12) during the second stage. Minimum inhibitory concentrations (MICs), demographics, antibiotic therapy, and surgical history were collected. The MICs at the time of the first-stage and second-stage surgeries were compared. RESULTS: Nine (30%) revisions had an increase in vancomycin MIC. Six had an increase from ≤0.5 to 1 μg/mL, 2 had an increase from ≤0.5 to 2 μg/mL, and 1 had an increase from 1 to 2 μg/mL. All of the 9 revisions with an increase in vancomycin MIC had vancomycin in spacer. CONCLUSION: Increases in the MICs were observed for vancomycin, the antibiotic widely used in cement spacers, in about one-third of the revisions. Despite the small sample size, the data from this preliminary study raise concern about the potential for emergence of resistant organisms between the stages of a 2-stage revision.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. George J, Newman JM, Klika AK, et al. Changes in Antibiotic Susceptibility of Staphylococcus aureus Between the Stages of 2-Stage Revision Arthroplasty. J Arthroplasty. 2018. PMID: 29502963. doi:10.1016/j.arth.2018.01.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。